Tina-quant Cardiac high sensitivity CRP III— 510(k) K260026

Substantially Equivalent

Roche Diagnostics

FDA 510(k) clearance K260026 for Tina-quant Cardiac high sensitivity CRP III, Substantially Equivalent on 2026-04-02. Applicant: Roche Diagnostics.

Clearance details

Applicant
Roche Diagnostics
Product code
Code NQD
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Indianapolis, IN, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.